Showing results (51-60 of 174) with videos related to
Sort By:
Pageof 18
The Breast Journal|July 17, 2019
Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institutionGiacomo Barchiesi, Amelia McCartney, Chiara Biagioni, et al.Cancer Treatment Reviews|December 28, 2020
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancerIlenia Migliaccio, Martina Bonechi, Amelia McCartney, et al.Breast (Edinburgh, Scotland)|January 12, 2018
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM studyAngelo Di Leo, Guy Jerusalem, Roberto Torres, et al.Breast Care (Basel, Switzerland)|December 14, 2017
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of ResponseCristina Guarducci, Martina Bonechi, Giulia Boccalini, et al.Cancer Treatment Reviews|February 2, 2019
The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise reviewLorenzo Rossi, Amelia McCartney, Irene De Santo, et al.Clinical Breast Cancer|July 31, 2019
Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast CancerLorenzo Rossi, Amelia McCartney, Emanuela Risi, et al.Current Medical Research and Opinion|January 26, 2010
Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancerBeth Sherrill, Angelo Di Leo, Mayur M Amonkar, et al.Breast (Edinburgh, Scotland)|October 1, 2013
The continued evidence from overviews: what is the clinical utility?Natalie Turner, Laura Biganzoli, Luca Malorni, et al.NPJ Breast Cancer|September 5, 2019
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratificationAmelia McCartney, Alessia Vignoli, Leonardo Tenori, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Adjuvant chemotherapy: which patient? What regimen?Natalie Turner, Laura Biganzoli, Luca Malorni, et al.Pageof 18